These are just a few of the things I found while I was working on the
FDASM Highlights for UM Stakeholders, pt. 1: Early Presenters as SWOT-Plus blogpost.
What If FDA Threw a Party and No One Came? BioPharma Participation in the Part 15 Social Media Meeting: http://www.eyeonfda.com/eye_on_fda/2009/11/what-if-fda-threw-a-party-and-no-one-came-biopharma-participation-in-the-part-15-social-media-meetin.html
NOTE: Evolution of the FDA’s engagement with social media in the context of the target audience.
Frydman, Gilles. #FDASM: + ca change, + c’est la meme chose. http://e-patients.net/archives/2009/11/fdasm-ca-change-cest-la-meme-chose.html
NOTE: One of the most honest, thoughtful and relevant pieces I’ve seen.
John Mack’s slides of survey results and overview of suggested best practices for social media engagement in pharma industry.
See also part two: http://www.slideshare.net/johnmackjr/social-media-rx-promotion-fda-part2
Pitts, Peter. The Caves of Caution, Complacency and Compliance. DrugWonks. http://www.drugwonks.com/blog_post/show/7051
NOTE: This is the essence of Peter’s comments as a speaker, and I really enjoyed his presentation greatly.
Pitts, Peter. The Super Bowl of Part 15 Hearings. DrugWonks. http://www.drugwonks.com/blog_post/show/7052
NOTE: Brief synopses speaker-by-speaker of highlights from the public forum.
Dose of Digital: A Sneak Preview of My FDA Social Media Hearing Testimony. http://www.doseofdigital.com/2009/11/sneak-preview-fda-social-media-hearing-testimony/
Dose of Digital: Three Things I Learned at the FDA Social Media Hearings and Three I Wish I Had. http://www.doseofdigital.com/2009/11/three-things-i-learned-at-the-fda-social-media-hearings-and-three-i-wish-i-had/
Other things I’ve found, but haven’t read or viewed yet.
The FDA Grapples with Rules for Social Media. http://www.burrillreport.com/article-1908.html
PhRMA Proposes FDA-Approved Use of Universal Safety Symbol for Branded Tweets & SE Ads. http://pharmamkting.blogspot.com/2009/11/phrma-proposes-fda-approved-use-of.html
Speaker highlights from Pixels & PIlls.
Vimeo: PN Perspectives: The FDA, Social Media and the Future of Health Care Communications. http://vimeo.com/7559619